These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 6111435)

  • 1. The disposition of DL-3-di-n-butylamino-1-[2,6-bis(4-trifluoromethylphenyl)-4-pyridyl] propanol methanesulfonate in mice.
    Chung H; Jimmerson VR; Sanders JE; Bounds DW; Rozman RS; Thorne J
    Drug Metab Dispos; 1981; 9(1):65-6. PubMed ID: 6111435
    [No Abstract]   [Full Text] [Related]  

  • 2. The disposition of threo-alpha-(2-piperidyl)-2-trifluoromethyl-6-(4-trifluoromethylphenyl)-4-pyridinemethanol phosphate in mice.
    Chung H; Gillum HH; Rozman RS
    Drug Metab Dispos; 1978; 6(1):82-6. PubMed ID: 23279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090.
    Mu JY; Israili ZH; Dayton PG
    Drug Metab Dispos; 1975; 3(3):198-210. PubMed ID: 238819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of antileukemic and trypanocidal compounds with amidino and imidazolinyl groups.
    Gluth WP; Busch U
    Arzneimittelforschung; 1984; 34(11):1542-51. PubMed ID: 6543129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of 6-amino-5-(N-methylformylamino)-1,3-dimethyluracil, one of the primary metabolites of caffeine, in the rat.
    Bonati M; Bortolotti A; Jiritano L; Latini R; Garattini S
    Drug Metab Dispos; 1983; 11(5):509-11. PubMed ID: 6138240
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxisuran metabolism in pigs.
    Crew MC; Di Carlo F
    Drug Metab Dispos; 1976; 4(2):147-53. PubMed ID: 5259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
    Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
    Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological disposition and metabolism of O-ethyl-O-4-nitrophenyl phenylphosphonothioate in male cats following a single dermal administration.
    Abou-Donia MB; Kinnes CG; Abdo KM; Bjornsson TD
    Drug Metab Dispos; 1983; 11(1):31-6. PubMed ID: 6132792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats.
    Wong YN; Quon CY; Holm KA; Burcham DL; Frey NL; Huang SM; Lam GN
    Drug Metab Dispos; 1996 Feb; 24(2):172-9. PubMed ID: 8742228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and disposition of sulfinalol in laboratory animals.
    Benziger DP; Fritz A; Edelson J
    Drug Metab Dispos; 1981; 9(6):493-8. PubMed ID: 6120804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism in man of oxisuran, a differential immunosuppressive drug.
    Crew MC; Vesell ES; Passananti GT; Gala RL; Di Carlo FJ
    Clin Pharmacol Ther; 1973; 14(6):1013-21. PubMed ID: 4584148
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of distribution of di-propranolol in various organs and discrete brain areas of the rat.
    Bianchetti G; Elghozi JL; Gomeni R; Meyer P; Morselli PL
    J Pharmacol Exp Ther; 1980 Sep; 214(3):682-7. PubMed ID: 7400970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE; Duncan GF; El Dareer SM; Hill DL
    Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and disposition of n-butyl glycidyl ether in F344 rats and B6C3F1 mice.
    Chen LJ; Lebetkin EH; Nwakpuda EI; Burka LT
    Drug Metab Dispos; 2007 Dec; 35(12):2218-24. PubMed ID: 17875671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of the carcinostatic agent 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha,beta-d-ribofuranosyl]-1-nitrosourea in animals.
    Godenèche D; Madelmont JC; Moreau MF; Montoloy D; Plagne R
    Cancer Res; 1980 Sep; 40(9):3351-6. PubMed ID: 7427947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of vatalanib (PTK787/ZK-222584) in cancer patients.
    Jost LM; Gschwind HP; Jalava T; Wang Y; Guenther C; Souppart C; Rottmann A; Denner K; Waldmeier F; Gross G; Masson E; Laurent D
    Drug Metab Dispos; 2006 Nov; 34(11):1817-28. PubMed ID: 16882767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pharmacokinetics and tissue distribution of thiotepa in mice.
    Egorin MJ; Akman SR; Gutierrez PL
    Cancer Treat Rep; 1984 Oct; 68(10):1265-8. PubMed ID: 6441641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of indicine N-oxide in mice and monkeys.
    El Dareer SM; Tillery KF; Lloyd HH; Hill DL
    Cancer Treat Rep; 1982 Jan; 66(1):183-6. PubMed ID: 7053256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of C14-labelled arteether in kidneys and livers of experimental mice after intramuscular injection.
    Cheeramakara C; Khachonsaksumet V; Suthisai N; Nakosiri W; Songmuaeng K; Saenghirun C; Phienpicharn D; Nontprasert A
    Southeast Asian J Trop Med Public Health; 2008 Mar; 39(2):195-9. PubMed ID: 18564701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
    Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA
    Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.